2009-11-10 18:18:03 -

SUNRx : cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww .. today announced that its automated discount drug solution is now available for children’s hospitals to implement and manage 340B drug discount programs, reduce costs, and help families with sick children save money on medications.

“New federal regulations allow children’s hospitals to save money and lower prescription costs by up to 60% for patients through the 340B program,” said SUNRx’s Jeff Rollins. “We are committed to helping children’s hospitals take advantage of their new eligibility and implement efficient and cost-effective discount medication programs immediately.”

The 340B Drug Pricing Program : cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww .. was created in 1992 to enable federally qualified health centers, disproportionate share hospitals and certain other entities maximize resources and expand access

to affordable medications. Despite the program’s benefits, complex regulations and paperwork requirements prevent many eligible entities from participating fully in 340B. In September 2009, the U.S. Health Resources and Services Administration (HRSA) issued new federal regulations : cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww .. to allow Children’s Hospitals to participate in the program.

SUNRx’s fully automated solution simplifies 340B implementation, management and compliance, and allows eligible entities to expand access to discount medications through in-house and contract pharmacies. SUNRx allows Children’s Hospitals to save money and focus resources on patient care by reducing paperwork, employee prescription benefits expenses, inventory carrying costs and other administrative burdens.

SUNRx is different from other 340B solutions in important ways to Children’s Hospitals. Many 340B solutions are the side businesses of large drug wholesalers and require hospitals to carry the parent company’s products and services. SUNRx allows Children’s Hospitals to choose any wholesaler, or any other partner, to achieve maximum flexibility and the lowest prices. SUNRx’s approach to formulary design and management is unique in the industry and allows Children’s Hospitals to tailor programs with medications used to treat childhood diseases.

“Our children’s hospitals across the country work every day to provide care to the most vulnerable among us,” said Rollins. “We applaud HRSA for expanding 340B eligibility to Children’s Hospitals,and we stand ready to help them implement efficient, effective 340B programs and provide children with medications they need at prices their families can afford.”


About SUNRx


Based in Mount Laurel, New Jersey, SUNRx, Inc. provides automated solutions for federally qualified health centers and disproportionate share hospitals for the administration of government 340B discount drug pricing programs. Community health centers nationwide rely on SUNRx to manage the complexities and risks associated with administering 340B, including management of sliding fee scales, formularies, reporting, payments, patient enrollment and eligibility, invoicing, inventory, patient drug cards and regulatory compliance, including diversion safeguards. For more information, please contact SUNRx at 800-220-340B, or visit www.340Bsimplified.com : cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww .. .


SUNRxMichael Rubin, 202-898-0995